Popular Mineral Water Sold at Costco Recalled Over Bacterial Contamination
Coca-Cola has issued a voluntary recall of 18-packs of 16.9-ounce glass Topo Chico mineral water due to possible contamination with Pseudomonas, a bacterium that can cause serious infections in people with weakened immune systems.
The recall affects products sold between May 20 and May 29 at 40 Costco locations across five states: Arizona, Louisiana, Nevada, New Mexico, and Texas. The impacted lot is labeled '#13A2541.'
No illnesses have been reported, and Coca-Cola states that the health risk is very low for the general population. Affected customers can return the product to Costco for a full refund.If you recently purchased any Topo Chico mineral water, then it's time to check your fridge or pantry.
On Wednesday, Coca-Cola issued a voluntary recall of its Topo Chico mineral water in five states due to concerns about potential contamination with a deadly bacteria for individuals with weakened immune systems known as Pseudomonas.
As the Centers for Disease Control and Prevention (CDC) explains, Pseudomonas is a group of bacteria that is "commonly found in the environment, like in soil and water." However, if it flourishes, it can "cause infections in the blood, lungs (pneumonia), urinary tract, or other parts of the body after surgery."
A spokesperson confirmed to USA Today that the bottles were shipped to 40 retail locations across Arizona, Louisiana, Nevada, New Mexico, and Texas, with Costco included among the affected retailers. Individuals who purchased contaminated Topo Chico are encouraged to return them to their local Costco for a full refund. Those who have further questions can call Coca-Cola at 1-800-GET-COKE (1-800-438-2653).
Related: The Food Recall System Is Broken, and Experts Say We're All at Risk
According to the brand's letter sent to Costco members on June 2, the recalled product bears the Lot Code #13A2541 on both the outer box and the neck of each bottle. It specifically affects the 18-packs of glass 16.9-ounce Topo Chico mineral water. The notice from Coca-Cola also stated that if you purchased one of the recalled packages, you can return it to your nearest Costco for a full refund. A Costco spokesperson noted that the products were all purchased between May 20 and May 29.
No illnesses have been reported in connection with the recall. Coca-Cola also noted that the health consequences for those who accidentally consume the mineral water containing pseudomonas are "very low." However, the CDC advises that those most at risk include anyone on "breathing machines, have devices such as catheters, [or] have open wounds from surgery or burns."
The Cleveland Clinic additionally noted that "It's rare for a Pseudomonas aeruginosa infection to develop in people with a healthy immune system. But it can be serious and potentially deadly if you have a weakened immune system (immunocompromised)." That includes individuals living with conditions such as lupus, rheumatoid arthritis, cancer, HIV, diabetes, liver disease, or those who are pregnant. Symptoms of an infection may include fever, chills, muscle pain, earache, headache, nausea, or vomiting. If you experience any symptoms, seek out a medical expert immediately. Product recalled: 18-packs of glass 16.9-ounce Topo Chico mineral waterReason for recall: Potential Pseudomonas contaminationLot Code: #13A2541 States affected: Arizona, Louisiana, Nevada, New Mexico, and TexasStores affected: 40 separate Costco locationsRead the original article on Food & Wine

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CBS News
2 hours ago
- CBS News
Public health officials confirm new measles case in LA County
Los Angeles County public health officials have confirmed a new measles case in a resident who recently traveled internationally and visited at least three Santa Clarita stores in recent weeks. According to a press release from the Department of Public Health, officials advised that the person visited: the Costco at 18659 Via Princessa from 10 a.m. to noon, the Trader Joes at 19037 Golden Valley Road from 2:30 p.m. to 4 p.m., and the Walmart at 25450, The Old Road, Stevenson Ranch, from 3:15 p.m. to 4:45 p.m. Officials say that other people who came in contact with the person may have been exposed. They advise that symptoms could arise within seven and 21 days, and residents are advised to verify their vaccination status. "Measles is a serious respiratory disease that spreads easily through the air and on surfaces, particularly among people who are not already protected from it," said County Health Officer Dr. Muntu Davis in a statement. "A person can spread the illness to others before they have symptoms, and it can take seven to 21 days for symptoms to show up after exposure. Measles can lead to severe disease in young children and vulnerable adults. The best way to protect yourself and your family from infection is with the highly effective measles vaccine." According to health officials, measles symptoms can include fever, cough, runny nose, red eyes and fatigue. People typically notice a red rash one to four days after symptoms first start, beginning on the head and then spreading to the lower body. This is now at least the 13th case of measles confirmed in California thus far this year, according to the California Department of Public Health. The first Los Angeles County case was reported back in March, however in February officials also noted that an Orange County infant with the disease traveled through LAX.
Yahoo
5 hours ago
- Yahoo
Oakland County issues alert for measles exposure site in Rochester Hills
FOX 2 - The Oakland County Health Division is notifying the public about a Rochester Hills measles exposure site involving a person from another county. The exposure site is a medical office building at 3950 S. Rochester Road at the corner of South Boulevard on Tuesday, June 3, according to a release from the Oakland County Health Division. Anyone there between 8 a.m. and 7:30 p.m. may have been exposed to measles. If you think you were exposed to measles at this location on June 3, Immune Globulin (IG) treatment is effective within six days of exposure for high-risk individuals. Those considered high-risk include women who are pregnant, unvaccinated children under age 5 and those who have a weakened immune system due to illness and disease including diabetes or HIV, malnutrition and/or medications. If you are not eligible for IG, monitor symptoms through June 24. If symptoms develop, call ahead to your health care provider. Individuals born in or before 1957 are considered immune. Measles is a highly contagious, vaccine-preventable disease that is spread by direct person-to-person contact and through the air. The Health Division recommends unvaccinated individuals ages 1 year and older receive a measles vaccination to protect themselves and those around them. Anyone who doesn't have a record of two MMR vaccines, unsure if they've have been vaccinated, or unsure if you've had measles in the past, needs to contact their health care provider. Measles can live for up to two hours in the air where an infected person coughed or sneezed. Symptoms of measles usually begin 7-14 days after exposure, but can appear up to 21 days after exposure, and may include: High fever (may spike to over 104°F Cough Runny nose Red, watery eyes (conjunctivitis) Tiny white spots on the inner cheeks, gums and roof of mouth (Koplik Spots) 2-3 days after symptoms begin. A rash that is red, raised, blotchy; usually starts on face, spreads to trunk, arms and legs 3-5 days after symptoms begin. The MMR vaccine is available through some health care providers, Oakland County Health Division offices in Southfield and Pontiac, and many pharmacies. Health Division offices are located at the following addresses: North Oakland Health Center, 1200 N. Telegraph Road, Building 34 East, Pontiac South Oakland Health Center, 27725 Greenfield Road, Southfield. Health Division clinics hours are Monday, Wednesday and Friday 8:30 a.m. – 5 p.m. Tuesday 9:30 a.m. – 6 p.m. and Thursday 7:30 a.m. – 5 p.m. Visit for more information on measles, or contact Nurse on Call, 8:30 a.m. to 5 p.m. Monday through Friday, at 800-848-5533 or noc@
Yahoo
11 hours ago
- Yahoo
Long-lasting HIV prevention shot heads toward approval
June 6 (UPI) -- A new vaccine to prevent HIV is expected to be approved by the U.S. Food and Drug Administration later this month. If approved, the shot -- lenacapavir -- would be given twice a year and could be a big step forward in the fight against HIV. Drugmaker Gilead Sciences tested the shot in a study of women and girls. None of the participants who received the injections got HIV. That early success helped boost Gilead's stock by 73% over the past year, The Wall Street Journal reported. "We know it's challenging to take a daily pill for prevention, and we see an incredible opportunity here," said Johanna Mercier, Gilead's chief commercial officer Right now, more than 400,000 people in the United States use pills to prevent HIV, The Wall Street Journal added. These medications are referred to as PrEP, short for pre-exposure prophylaxis. Gilead expects the number of users to top 1 million by the next decade. Many people already say they'd prefer a shot over daily pills. In one survey of more than 500 PrEP users, 95% said they would switch to a long-acting injection. Sales of other long-acting options, like the shot Apretude from GSK, have risen sharply - up 63% in the past year. Even with strong results, Gilead faces several hurdles. One is reaching the people who need PrEP the most. Black Americans represent 39% of new HIV cases but only 14% of current PrEP users. Many people still face stigma or lack insurance coverage, which can limit access. Gilead says reaching underserved groups is a top goal. Most current PrEP users have commercial insurance, but Medicaid will be key for expanding access to lower-income communities. Another concern: Some experts worry the new shot may simply replace current Gilead products, like the daily pill Descovy, which now holds about 40% to 45% of the market. But Gilead says the shot should help expand the overall number of people using PrEP in both the U.S. and abroad. "We're thinking globally about the public health impact we can have," Mercier said. The company is working with governments and health groups in the United Kingdom and low-income countries to raise awareness and make these products more available. More information The National Institutes of Health has more on Pre-Exposure Prophylaxis (PrEP). Copyright © 2025 HealthDay. All rights reserved.